Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
Treating cancer in children usually involves several types of therapy, all aimed at curing the disease, even if it has spread. Unlike in adults, where treatment may focus on comfort for advanced cancer, pediatric care aims for a cure. The main treatments are chemotherapy, surgery, and radiation, but newer options like immunotherapy and targeted drugs are now also used. Doctors follow international guidelines to make sure each child gets the best treatment for their specific situation.
The intensity of pediatric protocols is significantly higher than that of adults. Children have a higher physiological reserve and fewer comorbidities, allowing them to tolerate dose-intensive chemotherapy regimens that would be fatal in older adults. This “dose compression” is a key factor in the high cure rates of pediatric malignancies. However, this intensity requires rigorous supportive care to manage the acute toxicities, including myelosuppression, mucositis, and nutritional depletion. The treatment plan is not just about drug delivery; it is a holistic ecosystem of care involving infectious disease control, transfusion medicine, and nutritional support.
Chemotherapy remains the backbone of treatment for most pediatric cancers. The agents used are cytotoxic, targeting the DNA or metabolic machinery of rapidly dividing cells. Alkylating agents (Cyclophosphamide), Anthracyclines (Doxorubicin), Vinca Alkaloids (Vincristine), and Antimetabolites (Methotrexate) are combined in multi-agent schedules to prevent drug resistance.
The concept of “dose intensity” the amount of drug delivered per unit of time is critical. In Ewing Sarcoma and Neuroblastoma, “interval compression” (giving cycles every two weeks instead of three) has been shown to improve survival. For leukemia, treatment is prolonged and consists of distinct phases: Induction (to kill visible disease), Consolidation (to kill resistant clones), and Maintenance (low-dose therapy to prevent regrowth). Intrathecal chemotherapy, injected directly into the spinal fluid, is standard in leukemia to treat or prevent disease in the central nervous system, which is a sanctuary site protected from systemic drugs by the blood-brain barrier.
Surgery in pediatric oncology is highly specialized. The goal is complete resection (R0) while preserving function and growth potential. In Wilms’ tumor, nephron-sparing surgery (partial nephrectomy) is attempted in bilateral cases to protect renal function. In osteosarcoma, limb-salvage surgery has largely replaced amputation. This involves removing the bone tumor and reconstructing the limb with a metallic endoprosthesis or a biological graft.
For neuroblastoma, surgery is often delayed until after induction chemotherapy has shrunk the tumor, making it safer to remove it from around major blood vessels. In brain tumors, the objective is maximal safe resection removing as much tumor as possible without damaging eloquent areas of the brain controlling speech, motor function, or vision. Advanced techniques like intraoperative MRI and neuronavigation guide these delicate procedures.
Radiation therapy is a double-edged sword in pediatrics. It is highly effective at killing cancer cells but causes significant damage to developing tissues, leading to growth arrest, cognitive deficits, and secondary cancers. Therefore, modern protocols strive to omit or reduce radiation whenever possible. When radiation is necessary, precision is paramount.
Proton Beam Therapy represents the most significant technological advance in this domain. Unlike conventional X-rays (photons), which pass through the body and deposit an exit dose in healthy tissue, protons deposit their energy at a specific depth (the Bragg peak) and stop. This spares the healthy tissues behind the tumor. In a child with a brain tumor, this means sparing the developing hippocampus (memory), pituitary (hormones), and cochlea (hearing). In a child with a chest tumor, it means sparing the heart and healthy lung.
Immunotherapy is transforming pediatric care. Dinutuximab, a monoclonal antibody targeting the GD2 glycolipid on neuroblastoma cells, recruits the patient’s immune system to lyse the tumor and has become standard of care for high-risk disease. Blinatumomab is a bispecific T-cell engager (BiTE) that physically bridges T cells to leukemia cells, triggering an immune response.
The most revolutionary advance is CAR-T cell therapy. T-cells are harvested from the patient, genetically reprogrammed in a lab to express a receptor for CD19 (found on leukemia cells), expanded, and infused back into the patient. These “hunter” cells persist in the body, providing long-term surveillance. Current research is focused on developing the applicability of CAR-T to solid tumors and reducing the toxicity of Cytokine Release Syndrome associated with the therapy.
Precision medicine involves tailoring treatment to the specific mutations found in the tumor. For tumors with BRAF mutations (like some gliomas), BRAF inhibitors (Dabrafenib/Trametinib) can shrink tumors without the toxicity of chemotherapy. ALK inhibitors are used in Anaplastic Large Cell Lymphoma. TRK inhibitors (Larotrectinib) are effective in rare tumors driven by NTRK fusions, regardless of the organ of origin. This “histology-agnostic” approval marks a shift towards treating the mutation, not just the anatomical location.
The most revolutionary advance is CAR-T cell therapy. T-cells are harvested from the patient, genetically reprogrammed in a lab to express a receptor for CD19 (found on leukemia cells), expanded, and infused back into the patient. These “hunter” cells persist in the body, providing long-term surveillance. Current research is focused on developing the applicability of CAR-T to solid tumors and reducing the toxicity of Cytokine Release Syndrome associated with the therapy.
Send us all your questions or requests, and our expert team will assist you.
Standard radiation uses X-rays (photons) that pass through the body, depositing radiation in healthy tissues behind the tumor. Proton therapy uses particles that stop precisely at the tumor site, delivering the dose to the cancer while sparing the healthy developing organs behind it, which is crucial for growing children.
CAR-T therapy is a type of immunotherapy in which a child’s own T cells (immune cells) are collected and genetically engineered in a lab to express a special receptor (CAR). This receptor acts like a GPS, finding and destroying leukemia cells. Once infused back into the child, these cells hunt down the cancer.
Children’s bodies are more resilient than adults’ and can tolerate higher doses of chemotherapy, which are often necessary to cure aggressive pediatric cancers. Because children’s organs are generally healthier, they can recover from the temporary damage to bone marrow and linings better than older adults, allowing for “dose-intensive” curative regimens.
Limb-salvage surgery is a procedure to remove a bone tumor (like osteosarcoma) without amputating the arm or leg. The surgeon removes the bone containing the tumor and replaces it with a metal implant (endoprosthesis) or a bone graft. This preserves the appearance and function of the limb.
Targeted therapies are drugs designed to attack specific genetic mutations that drive the cancer’s growth, rather than just killing all fast-growing cells like chemotherapy does. For example, if a tumor has a particular gene mutation that drives its growth, a targeted inhibitor blocks that gene’s signal, causing the cancer to shrink with fewer general side effects.
Knowing what a polyp is is key to understanding colorectal cancer risk. A polyp is a growth inside the colon or rectum. Most are harmless,
Are polyps scary in kids? Discover amazing facts about childhood health and find powerful ways to protect your family’s vital digestion. Polyps in the gut
Getting a cancer diagnosis can feel like a lot to handle. But, it’s key to take the right steps for the best treatment. Research indicates
Many think cancer leads to unintentional weight loss. But, some cancers cause weight gain. Obesity-related cancers, like breast cancer and endometrial cancer, are often linked
Nuclear medicine is key in finding and treating childhood diseases. Pediatric nuclear medicine is common and used often in kids’ care. Every year, almost 370,000
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
